Bio-Techne Investors Website

Where Science Intersects Innovation™

As Bio-Techne, we have united multiple brands to provide a unique and comprehensive product portfolio. Together, our brands provide world class products and services for life-science research and clinical applications.

Investor Presentation

Latest Presentation

June 20, 2024

Corporate Presentation – June 2024

View Presentation View All


Adjusted Gross Margin of 71.9%


Adjusted EPS of $0.48


Revenue of $303.4 million

Sign up for E-Mail Alerts

Sign up today

Stock Information

Bio-Techne Corporation

Nasdaq: TECH

 |  View Detailed Stock Info

Day Range
52 Week Range

Company Overview

Bio‑Techne is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics. Whether you’re at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our award-winning tools and solutions empower scientists and clinicians to achieve reproducible and consistent results. Trusting Bio‑Techne means choosing confidence that every solution you use will help move you toward better answers.

Fast Facts

Net Sales (July 2022 to June 2023)

$1.1 Billion

Employees Worldwide




Journal citations


Incorporated in Minneapolis, Minnesota



Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is a source of our success.

IR Contact Information

Company Information

Corporate Secretary
614 McKinley Place NE
Minneapolis, MN 55413

Investor Relations

David Clair
T: 612-656-4416

Transfer Agent

American Stock Transfer
6201 15th Avenue
Brooklyn, NY 11219
T: 800-937-5449